11/7/2012 9:56:59 AM
SAN DIEGO, Nov. 6, 2012 /PRNewswire/ -- Volcano Corporation (VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today reported results for the third quarter of 2012.
For the quarter ended September 30, 2012, Volcano reported revenues of $93.7 million, an increase of nine percent on a reported basis and 12 percent on a constant currency basis after adjusting for a three percent negative impact from foreign currency. Medical segment revenues increased nine percent on a reported basis and 12 percent on a constant currency basis versus the third quarter a year ago.
comments powered by